Nymox Pharma (NYMX) PR is a Repeat of Same Talking Points - Feuerstein

August 29, 2016 10:37 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

TheSteet's Adam Feuerstein issues cautious comments on Nymox Pharma (NASDAQ: NYMX) after the company's latest release.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Short Sales, Trader Talk

Related Entities

Adam Feuerstein

Add Your Comment